↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID21948594.edit
↑Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P (July 1999). „Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist”. Nature400 (6742): 371–5. DOI:10.1038/22560. PMID10432116.
↑Beardsley PM, Sokoloff P, Balster RL, Schwartz JC (February 2001). „The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered”. Behavioural Pharmacology12 (1): 1–11. PMID11270507.
↑Garcia-Ladona FJ, Cox BF (2003). „BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction”. CNS Drug Reviews9 (2): 141–58. PMID12847556.
↑Duarte C, Lefebvre C, Chaperon F, Hamon M, Thiébot MH (November 2003). „Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats”. Neuropsychopharmacology28 (11): 1903–15. DOI:10.1038/sj.npp.1300276. PMID12915863.
↑Hsu A, Togasaki DM, Bezard E, Sokoloff P, Langston JW, Di Monte DA, Quik M (November 2004). „Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys”. The Journal of Pharmacology and Experimental Therapeutics311 (2): 770–7. DOI:10.1124/jpet.104.071142. PMID15226382.
↑Gilbert JG, Newman AH, Gardner EL, Ashby CR, Heidbreder CA, Pak AC, Peng XQ, Xi ZX (July 2005). „Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors”. Synapse (New York, N.Y.)57 (1): 17–28. DOI:10.1002/syn.20152. PMID15858839.
↑Hocke C, Prante O, Salama I, Hübner H, Löber S, Kuwert T, Gmeiner P (May 2008). „18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor”. Chemmedchem3 (5): 788–93. DOI:10.1002/cmdc.200700327. PMID18306190.